Avior Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Avior Wealth Management's ARKG Position: Q1 2025 in Review
Avior Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 5,639 shares — an estimated $133K sold.
Avior Wealth Management first reported a position in ARKG in Q2 2020 and held it in 19 quarters. The position peaked at $1.38M in Q2 2023. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Avior Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Avior Wealth Management sold 5,639 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $133K.
- Avior Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 19 quarters.
- Avior Wealth Management's ARK Genomic Revolution ETF position peaked at $1.38M in Q2 2023.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.